http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3763724-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9019c0ce5cb7b82c85e121f6cac86dce |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 |
| filingDate | 2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cedcf44e4eddf1052f0984eb584cb736 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88d18d4a6ce2391f4182d4e9bb5243f5 |
| publicationDate | 2021-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3763724-A1 |
| titleOfInvention | ß-MODIFIED PHOSPHORIC ACID COMPOUND PRECURSOR, ß-MODIFIED PHOSPHORIC ACID COMPOUND, REACTION INHIBITOR, AND MEDICINE INCLUDING SAME, AND REACTION INHIBITION METHOD |
| abstract | Provided is a β-modified phosphoric acid compound precursor having a partial structure represented by formula 1A in the molecule thereof. Further, provided are a reaction inhibitor and a medicine, each of which includes the β-modified phosphoric acid compound precursor. (In the formula, A<sub>1</sub> represents -SR<sub>1</sub>, -S-S-R<sub>1</sub>, - SeR<sub>1</sub>, or -X (where X means a halogen selected from fluorine, chlorine, bromine, and iodine), R<sub>1</sub> represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like, L<sub>1</sub> represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like, L<sub>2</sub> represents an alkyl group having 1 to 20 carbon atoms, or the like, L<sub>1</sub> and L<sub>2</sub> may be linked to each other to form a 4 to 6-membered ring structure, L<sub>1</sub> and L<sub>2</sub> may each have a substituent, and the symbol * represents a bond to be bonded to a phosphate group by phosphorylation.) |
| priorityDate | 2018-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 257.